Phanes Therapeutics,Inc. – Trademark Portfolio

Entity Type: 03

Phanes Therapeutics,Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include PACBODY, SPECPAIR, ATACCBODY, and PHANES THERAPEUTICS. The owner is based in SAN DIEGO, CA.

9215 BROWN DEER ROAD, SUITE B

SAN DIEGO, CA 92121

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Phanes Therapeutics,Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (8 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Phanes Therapeutics,Inc. have?

Phanes Therapeutics,Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 5 registered, 7 abandoned.

What trademark classes does Phanes Therapeutics,Inc. file in?

Phanes Therapeutics,Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Phanes Therapeutics,Inc.'s most well-known trademarks?

Phanes Therapeutics,Inc.'s registered trademark portfolio includes well-known marks such as PACBODY, SPECPAIR, ATACCBODY, and PHANES THERAPEUTICS. These are among 5 currently registered trademarks in the portfolio.

What is Phanes Therapeutics,Inc.'s trademark registration success rate?

Phanes Therapeutics,Inc. has a 42% trademark registration rate, with 5 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.